"Claritas Pharmaceuticals (TSXV:KLY) has added Professor Salvatore Cuzzocrea, Ph.D. to their Board of Directors
Claritas Pharmaceuticals (KLY) has added Professor Salvatore Cuzzocrea, Ph.D. as an independent member of the company’s board of directors, effective immediately.